BioOrbit's funding has not been publicly disclosed.

BioOrbit

Pharma crystals grown in microgravity

In-Space Manufacturing United KingdomSeedWebsite ↗

BioOrbit operates in the in-space manufacturing sector of the space industry, is headquartered in United Kingdom, was founded in 2023, is at Seed stage.

BioOrbit at a glance

Status	Activechecked August 2026
Sector	In-Space Manufacturing
Headquarters	United Kingdom
Founded	2023
Stage	Seed
Website	bioorbit.com

Record last updated August 2026 · how we verify · spotted something outdated? Tell us.

Timeline & funding

May 2026Funding
Closes a £9.8M seed co-led by LocalGlobe and Breega↗
April 2026Funding
Seed: GBP 9.8M, reported as the largest seed round yet for in-space manufacturing↗Co-led by LocalGlobe and Breega, with Auxxo, Seedcamp, Type One Ventures and 7percent Ventures
June 2025Anomaly
Its first crystallisation unit is lost when The Exploration Company’s capsule fails to land↗
November 2023Contract
Joins the ESA business incubator in the UK with UK Space Agency support↗

Backed by

Investors in BioOrbit who also back other space companies we track.

Type One Ventures · 4 space companies 7percent Ventures · 3 space companies

Mission

Crystallizing pharmaceutical proteins in microgravity for better cancer drugs.

Follow startups like BioOrbit

Founder interviews and the most promising space startups, straight to your inbox. Free, no spam, unsubscribe anytime.